Human CCL19/MIP-3 beta Antibody, R&D Systems™

CCL19/MIP-3 beta

Neutralization 0.1-0.5 ug/mL

Monoclonal

Purified

RUO

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

beta chemokine exodus-3, Beta-chemokine exodus-3, CC chemokine ligand 19, C-C motif chemokine 19, chemokine (C-C motif) ligand 19, CKb11, EBI1-ligand chemokine, ELC, ELCMIP-3-beta, Epstein-Barr virus-induced molecule 1 ligand chemokine, exodus-3, Macrophage inflammatory protein 3 beta, macrophage inflammatory protein 3-beta, MGC34433, MIP3 beta, MIP-3 beta, MIP-3b, MIP3BCK beta-11, SCYA19EBI1 ligand chemokine, small inducible cytokine subfamily A (Cys-Cys), member 19, Small-inducible cytokine A19

CCL19

IgG1

Protein A or G purified from hybridoma culture supernatant

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

948918

Neutralization

Unconjugated

Mouse

Human

Q99731

6363

E. coli-derived recombinant human CCL19/MIP-3 beta Gly22-Ser98 Accession # Q99731

Primary

Reconstitute at 0.5 mg/mL in sterile PBS.

Detects human CCL19/MIP-3 beta in direct ELISAs.